FDA commish Hamburg looks to spur med-tech innovation

FDA commissioner Dr. Margaret Hamburg

Dr. Margaret Hamburg, the head of the FDA, put out a blueprint for spurring innovation in the life sciences today, saying there aren’t enough new products in the med-tech pipeline to suit her.

"The number of new products in the development pipeline is not where we would want it to be and it’s not commensurate with the medical and public health need," Hamburg said during a conference call this afternoon.

The blueprint, "Driving Biomedical Innovation: Initiatives for Improving Products for Patients," includes calls for the federal watchdog agency to improve "consistency and clarity in the medical device review process," rebuild its outreach offering for small businesses and focus on developing personalized medicine, according to a press release.

Sign up to get our free newsletters delivered right to your inbox

"We know that investment in biomedical research and product development are at all-time highs – last year an estimated $100 billion from the public and private sector – but the return on investment, in terms of new products for people and to the companies, has not been what was expected," Hamburg said during the call. "Timelines are long, costs are high, rates of failure are distressingly high, so this is a critical time to come together to address this important issue for people and for our nation."

The FDA is launching an Entrepreneurs in Residence program to bring outside experts into the fold, including the recently retired CEO of Medtronic (NYSE:MDT), Bill Hawkins. Hamburg said the initiative is aimed at improving the agency’s understanding of "the business context that is important for us to better understand as we undertake our regulatory review."

"We think that it’s very, very important that we have this kind of cross-fertilization, with industry and academia and government all working together to help ensure that we have the understanding and the systems in place and the tools that we need to be able to translate from scientific discoveries into real-world product," she said during the call.

The blueprint, released during Hamburg’s appearance at the Washington Ideas Forum, drills down to seven areas of focus:

  • “rebuilding FDA’s small business outreach services
  • building the infrastructure to drive and support personalized medicine
  • creating a rapid drug development pathway for important targeted therapies
  • harnessing the potential of data mining and information sharing while protecting patient privacy
  • improving consistency and clarity in the medical device review process
  • training the next generation of innovators
  • streamlining and reforming FDA regulations”

In addition to Hawkins, EIR’s "strategic team" includes:

  • Jeff Allen, Friends of Cancer Research
  • Francis Beland, XPrize Foundation
  • Riley Crane, MIT Media Lab
  • John Driscoll, MEDCO
  • Dr. Elazer Edelman, MIT/Harvard Medical
  • Dr. Thomas Fogarty, Fogarty Institute for Innovation
  • Mark Jeffrey, Kellogg School
  • Mark Johnson, Innosight
  • Dean Kamen, DEKA Research
  • Anjali Kataria, Conformia
  • Thane Kreiner, Santa Clara University
  • Jack Lasersohn, The Vertical Group
  • Dr. Roger Lewis, UCLA Medical Center
  • Ken Miller, Change and Innovation Agency
  • Dr. Jeffrey E. Shuren, FDA (team leader)

The "tactical team" includes:

  • Dorothy Abel, CDRH
  • Patrick Axtell, CDRH
  • Frank Baitman, EIR Fellow
  • Dr. Michael Callahan, DARPA
  • Dr. David Chan, MIT
  • Siromi Gardina, CDRH
  • Telba Irony, CDRH
  • Megan Moynahan, CDRH (team leader)
  • Daya Ranamukhaarachchi, CDRH
  • Dr. Paul Sobotka, Ardian Inc.
  • Elizabeth Stafford, CDRH
  • Mr. Kwame Ulmer, CDRH
  • Maj. Gen. Tom Wilkerson, USMC (Ret.), EIR Fellow
  • David Windt, CDRH

RSS From Medical Design & Outsourcing

  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]
  • TSO3 begins shipment of STERIZONE VP4 Sterilizers to U.S.
    TSO3, a developer in sterilization technology for medical devices in healthcare settings, announced that the company has received purchase orders for multiple devices from the U.S. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and TSO3. “Finally,” said R.M. Rumble, president and CEO of TSO3. “Our Vision is […]
  • Turkish medical company is seeking reseller and OEM partners in the U.S.
    UZUMCU Medical Equipment, one of Turkey’s first and largest manufacturers of medical devices, is seeking reseller and OEM partners in the U.S. The company has an array of FDA-certified OR tables, surgical lights, surgical suction units, electro devices and other medical equipment. “We want to bring our experience with distributors throughout Europe and the Middle […]
  • QImaging introduces new CCD cameras for microscopy with modern software to streamline image capture
    QImaging, a manufacturer of scientific cameras for life science and OEM applications, introduces a new series of Retiga CCD cameras, accompanied by QImaging’s new acquisition software to deliver high-performance tools for microscopy and imaging to researchers at an affordable price. The new QImaging Retiga R1, Retiga R3 and Retiga R6 cameras offer valuable technical features […]
  • Sigma-Aldrich announces a new certification to aid IVD customers
    Sigma-Aldrich, a life science and high technology company, announced the company has received ISO 13485 certification for expanded quality assurance capabilities at its Dekalb and Barton facilities located in St. Louis. The certification extends Sigma-Aldrich’s ability to manufacture and offer critical raw materials, such as enzymes, proteins and antibodies used in diagnostic assays, and supplies in vitro […]
  • Prescribing the right power supply: Important considerations for using batteries to power medical devices
    Sol Jacobs, VP and General Manager, Tadiran Batteries Medical technology is advancing rapidly, requiring increasingly sophisticated power management solutions, especially when then the device needs to be self-powered. Battery-powered medical devices encompass a wide range of applications, including surgical drills, power tools, automatic external defibrillators (AEDs), infusion pumps, bone growth stimulators and other wearable devices, […]
  • Qosina announces the launch of its e-commerce website
    Qosina is pleased to announce the launch of its e-commerce website, making it easier to purchase thousands of medical device components from stock inventory. Visitors coming to the new Qosina.com will discover a new look and feel and improvements with every click including: · Easy navigation: A new category structure that mirrors the print catalog […]
  • Athermal laser machining for medical implants is the topic of Norman Noble’s latest whitepaper
    Thermal lasers have achieved extraordinary results in microprecision manufacturing of medical implants and devices the past 20 years. Devices we take for granted today, such as vascular stents, could not be produced without the technology; however, there are still significant limitations on what medical implant and device manufactures can produce using thermal lasers. One major issue […]
  • Sealevel announces the SeaISO family of USB isolators
    Sealevel announces the SeaISO family of USB isolators with 4 kV of medical-grade optical isolation between the host computer and connected USB equipment. SeaISO USB isolators are UL Recognized, in accordance with EN60601-1 3rd Edition, and protect both the power and data lines of connected USB devices from harmful ground loops, damaging transients and surges […]
  • The 21st Century Cures Discussion document recently released to the public
    It has been reported that among the 10,000 known diseases, 7,000 of which are considered rare, there are treatments for only 500. According to Dr. Francis Collins, Director of the National Institutes of Health (NIH), it now takes “around 14 years and $2 billion or more” to develop a new drug and “more than 95% […]

Leave a Reply